Larry Ellison, co-founder of Oracle Corporation, has an estimated net worth of approximately $200 billion, currently placing him among the third richest person in the world, according to Forbes.
He previously floated a joint venture, saying that the US should be entitled to half of the app.
Other potential buyers include the philanthropist Frank Mccourt ’s Project Liberty, which is raising capital to make a bid for TikTok in order to “rearchitect the platform” and protect user data. McCourt is a billionaire who previously owned the Los Angeles Dodgers baseball team. The project is supported by the social psychologist Jonathan Haidt.
As the clock ticks down on TikTok's 75-day reprieve from divesting from its Chinese owners or being banned in the United States, several contenders are in the running.
Content creator Jimmy Donaldson, known on the Internet as MrBeast, has made it clear he is interested in buying TikTok. Donaldson has the most subscribers of any user on YouTube— over 340 million—and boasts over 113 million TikTok followers.
Content creator Jimmy Donaldson, known on the Internet as MrBeast, has made it clear he is interested in buying TikTok. Donaldson has the most subscribers of any user on YouTube— over 340 million—and boasts over 113 million TikTok followers.
Robby Soave and Niall Stanage weigh in on debate of using A.I. to develop mRNA vaccines to target cancer. #AI #mrnavaccines
YouTuber MrBeast, X owner Elon Musk and Oracle Chairman Larry Ellison are names that have floated around in the past week.
US tech titans Elon Musk, Mark Zuckerberg and Jeff Bezos are taking a prominent place in the new Trump era, but another player from another era -- Oracle boss Larry Ellison -- is making a surprise return.
Billionaire Larry Ellison’s backing of Stargate — a landmark, $500 billion artificial intelligence infrastructure project touted by President Trump — could help grease the wheels for the embattled merger between Paramount Global and Skydance Media,
The American markets were spooked by the DeepSeek AI storm on Monday, January 27. While Dow Jones closed in green with minor gains, the tech-heavy Nasdaq closed with colossal losses of 612.47 points,
MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to represent a sustainable long-term revenue generator.